Navigation Links
ASTRO publishes supplement on protecting cancer patients by reducing radiation doses, side effects

The Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) review has been published in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO) to update recommendations for the safe irradiation of 16 organs. For each organ, the relationship between dose/volume and clinical outcome is reviewed. These reviews replace initial recommendations published in 1991.

When physicians began using radiation therapy to treat cancer, there was limited technology available to image a tumor and then target radiation specifically to it while limiting the dose to nearby healthy tissues. In the 1980s and 1990s, the field of imaging was revolutionized through the use of computed tomography-based diagnosis and radiation therapy treatment planning, allowing for treatments to be targeted more directly to the tumor and minimizing exposure to surrounding tissues.

No radiation treatment can be given while avoiding all nearby healthy tissue, but unlike cancer cells, normal tissue cells can repair themselves after receiving radiation. The QUANTEC review was published to help the radiation oncology treatment team decide which areas of healthy tissue surrounding a tumor can most safely receive radiation and to provide guidance for selecting doses/volumes to be treated.

The review also highlights areas in which there are gaps in knowledge and outlines future research in these areas.

"The information provided in the QUANTEC review is critical to providing cancer patients with the most effective radiation treatments to cure their cancer while minimizing side effects to normal tissue," Randall K. Ten Haken, Ph.D., one of the guest editors of the QUANTEC review and a professor at the University of Michigan Department of Radiation Oncology in Ann Arbor, Mich., said. "The field of radiation oncology is growing rapidly, and it's very important to know the limitations of the human body in receiving radiation; the QUANTEC review helps provide this information."

These reviews were produced through an extensive two-year project led by a QUANTEC steering committee comprising Dr. Ten Haken and fellow guest editor Lawrence B. Marks, M.D., a radiation oncologist at the University of North Carolina, Chapel Hill, as well as Sren M. Bentzen, Ph.D., D.Sc., University of Wisconsin in Madison, Wis., Louis S. Constine, M.D., University of Rochester in Rochester, N.Y., Joseph O. Deasy, Ph.D., Washington University in St. Louis, Avraham Eisbruch, M.D., University of Michigan in Ann Arbor, Mich., and Andrew Jackson, Ph.D., and Ellen D. Yorke, Ph.D., both from Memorial Sloan-Kettering Cancer Center in New York. Mary K. Martel, Ph.D., from M.D. Anderson Cancer Center in Houston served as an associate guest editor.

More than two dozen of the world's leading radiation oncologists, medical physicists and radiobiologists worked together on this extraordinary publication. The supplement can be found online at


Contact: Beth Bukata
American Society for Radiation Oncology

Related medicine news :

1. Gastroenterology sets standards for CT colonography
2. ASTRO, Wellness Community South Bay Cities Join to Promote Cancer Survivorship
3. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
4. CYNACON/OCuSOFT (OCuSOFT, Inc.) Names Katherine M. Mastrota, M.S., O.D. to Medical Scientific Advisory Board
5. Frequently Asked Questions When Considering a Colorectal Cancer Screening Test, From the American College of Gastroenterology
6. Anti-depressant drugs can double risk of gastrointestinal bleeding
7. Endoscopic resection is a safe and effective treatment for gastrointestinal smooth muscle tumors
8. President of Uruguay to Speak at ASTRO Annual Meeting
9. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO 2007
10. Varian Medical Systems to Introduce RapidArc(TM) Radiotherapy Technology for Volumetric Arc Therapy at ASTRO 2007
11. Acute pancreatitis and cholangitis: a complication caused by a migrated gastrostomy tube
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Purdue ... in the Life Sciences Initiative aimed at enhancing Purdue’s life sciences research and ... “Ever True” capital campaign. , The investment will result in cohesive efforts across ...
(Date:10/13/2015)... ... 2015 , ... Sir Grout of Greater Boston donated an expansive, seven room ... McDonald House Charities® (RMHC®). This donation was made in an effort to give back ... its inception. , “We believe strongly in the Ronald McDonald House Charities, and they ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... in the United States, today announced the release of its limited edition holiday ... Cranberry Cocktail Agua Fresca. All feature the unique flavor combinations and delicious taste ...
(Date:10/13/2015)... ... , ... According to an article published October 5th by the ... lose weight with a bariatric procedure are much less likely to develop endometrial cancer, ... anywhere from 40 to 50 percent of all endometrial cancer cases are caused by ...
(Date:10/13/2015)... , ... October 13, 2015 , ... Symposium Chairman, Dr. ... 19th annual Dallas Cosmetic Symposium to be held March 2nd and 3rd, 2016. The ... afterwards, draws plastic surgeons and cosmetic physicians from around the world. , Key topics ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... SHANGHAI , Oct. 13, 2015 ... R&D capability and technology platform company serving the ... that it has launched a mobile version of ... allow researchers to access oncology models and data ... clients anywhere and at any time to identify ...
(Date:10/13/2015)... , Oct. 13, 2015  The ... Harvard University today announced the launch of ... Ultivue will introduce imaging reagents providing ... to those of expensive specialized instruments. The ... Harvard,s Office of Technology Development (OTD) ...
(Date:10/13/2015)... , October 13, 2015 --> ... ,What can be expected from the Asthma and COPD Therapies ... rates? Visiongain ,s brand new report shows you potential ... ,  ,Our 309-page report provides 260 tables, charts, and graphs. ... future market prospects. Our new study lets you assess forecasted ...
Breaking Medicine Technology: